Skip to content
stoqly

Quaker Chemical

KWR NYSE Specialty Chemicals Financials FY2016–FY2025

Quaker Chemical's revenue rose 2.7% to $1.9 billion in fiscal 2025. Its operating margin was 2.8%, down from 10.6% a year earlier. Free cash flow was $81 million, down 50.5%. It paid out $76 million in dividends and buybacks, 94% of free cash flow. The diluted share count fell 2.2%.

Last close · Oct 23, 2026

$155.91

0.4%
Value it Compare
Revenue Total sales reported in the income statement.
$1.9B
2.7% vs prior year
Operating margin Operating income as a share of revenue.
2.8%
7.8 pts
Net income Profit after all expenses, interest and tax.
−$2.5M
102.1%
Free cash flow Cash from operations minus capital spending.
$80.6M
50.5%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
1.3%
5.5 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$2.7B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
27.8x
On $5.61 EPS (TTM)

What Quaker Chemical does

No business description yet.

Legal name
QUAKER CHEMICAL CORPORATION
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0001628280-26-010694
0000081362

Revenue and margins

Quaker Chemical had $1.9B of revenue in fiscal 2025, up 2.7% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $80.6M in fiscal 2025, 4.3% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Quaker Chemical returned $75.9M to shareholders in fiscal 2025, 94% of free cash flow. The diluted share count fell 2.2%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Quaker Chemical yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$726M and divides by 17.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 27.8x · peers 27.9x · sector 20.1x.

Balance sheet

Cash, debt and the ratios that show how comfortably Quaker Chemical can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $165M$181M$195M$189M$180M
Debt incl. finance leases $893M$964M$779M$745M$906M
Net debt / EBITDA 3.4x6.9x2.1x2.2x6.1x
Debt / equity 0.6x0.8x0.6x0.6x0.7x
Interest coverage 6.7x1.6x4.2x4.8x1.2x
Current ratio 2.1x2.8x2.5x2.3x2.4x
Quick ratio 1.5x2.0x1.9x1.7x1.7x
Total assets $3.0B$2.8B$2.7B$2.6B$2.8B
Total liabilities $1.6B$1.5B$1.3B$1.3B$1.4B
Shareholders' equity $1.4B$1.3B$1.4B$1.4B$1.4B
Net debt (− = net cash) $728M$783M$584M$556M$726M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.2M

2 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Aug 4, 2026 William H OsborneDirector Sold 600 $168.31 $0.1M Form 4
May 26, 2026 Jeewat BijlaniEVP, Glob. Spec. & CGO Sold 731 $145.77 $0.1M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✕
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✓ ✓ ✕
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✓ ✓ ✕
Current ratio rose ✕ ✕ ✓
Share count didn't rise ✕ ✓ ✓
Gross margin rose ✓ ✓ ✕
Revenue rose relative to assets ✓ ✕ ✓
F-score 7 / 97 / 95 / 9
Accruals ratio −6.0%−3.3%−5.1%
Altman Z'' 3.643.673.11

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Quaker Chemical KWR $2.7B 2.7% 2.8% 4.3% 1.3% 27.8x 5
Innospec IOSP $2.4B −3.7% 7.3% 5.0% 11.1% 20.1x 6 Compare →
Minerals Technologies MTX $2.0B −2.2% 2.3% 4.2% 1.6% — 4 Compare →
Sensient Technologies SXT $5.7B 3.5% 12.9% 2.4% 8.9% 35.8x 6 Compare →
Stepan SCL $1.5B 7.0% 3.4% 1.1% 3.6% — 6 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $747M $820M $868M $1.1B $1.4B $1.8B $1.9B $2.0B $1.8B $1.9B
Gross profit $280M $292M $312M $392M $513M $595M $613M $706M $686M $679M
Research and development $22.5M $23.9M $24.5M $32.1M $40.0M $44.9M $46.0M $50.3M $57.3M $60.7M
Operating income $85.4M $62.7M $87.8M $46.1M $59.4M $151M $52.3M $215M $195M $53.0M
Interest expense $2.9M $1.4M $4.0M $17.0M $26.6M $22.3M $32.6M $50.7M $41.0M $44.0M
Pretax income $84.0M $60.7M $83.1M $28.9M $27.1M $147M $7.1M $153M $155M $7.0M
Income tax $23.2M $41.7M $25.0M $2.1M −$5.3M $34.9M $24.9M $55.6M $49.3M $24.6M
Net income $61.4M $20.3M $59.5M $31.6M $39.7M $121M −$15.9M $113M $117M −$2.5M
Diluted EPS $4.63 $1.52 $4.45 $2.08 $2.22 $6.77 −$0.89 $6.26 $6.51 −$0.14
Diluted shares 0.01B 0.01B 0.01B 0.02B 0.02B 0.02B 0.02B 0.02B 0.02B 0.02B
Cash flow
Cash from operations $73.8M $64.8M $78.8M $82.4M $178M $48.9M $41.8M $279M $205M $137M
Capital expenditure $10.0M $10.9M $12.9M $15.5M $17.9M $21.5M $28.5M $38.8M $41.8M $55.9M
Free cash flow $63.8M $53.9M $65.9M $66.8M $160M $27.5M $13.3M $240M $163M $80.6M
Depreciation and amortization $7.1M $7.5M $7.5M $27.1M $57.5M $62.6M $60.7M $60.8M $60.9M $65.8M
Stock-based compensation $6.3M $4.2M $3.7M $4.9M $11.0M $11.0M $11.7M $14.6M $15.0M $13.6M
Acquisitions $15.0M $5.4M $0.5M $893M $56.2M $42.4M $13.1M $0.0M $39.3M $164M
Share buybacks $5.9M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $49.2M $41.5M
Dividends paid $17.6M $18.6M $19.3M $21.8M $27.6M $28.6M $30.1M $31.6M $33.2M $34.4M
Dividends and buybacks $23.5M $18.6M $19.3M $21.8M $27.6M $28.6M $30.1M $31.7M $82.4M $75.9M
Balance sheet
Cash and short-term investments $88.8M $89.9M $104M $124M $182M $165M $181M $195M $189M $180M
Total debt $65.8M $61.1M $36.6M $921M $888M $893M $964M $779M $745M $906M
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $377M $407M $419M $716M $793M $920M $994M $928M $876M $921M
Current liabilities $127M $155M $152M $360M $383M $431M $355M $368M $380M $380M
Inventory $77.1M $87.2M $94.1M $175M $188M $265M $285M $234M $228M $266M
Property and equipment, net $85.7M $86.7M $83.9M $214M $204M $198M $199M $208M $230M $313M
Total assets $692M $722M $710M $2.9B $2.9B $3.0B $2.8B $2.7B $2.6B $2.8B
Total liabilities $279M $313M $273M $1.6B $1.6B $1.6B $1.5B $1.3B $1.3B $1.4B
Shareholders' equity $403M $408M $435M $1.2B $1.3B $1.4B $1.3B $1.4B $1.4B $1.4B
Margins
Gross margin 37.5% 35.5% 36.0% 34.6% 36.2% 33.8% 31.5% 36.1% 37.3% 36.0%
Operating margin 11.4% 7.7% 10.1% 4.1% 4.2% 8.5% 2.7% 11.0% 10.6% 2.8%
EBITDA margin 12.4% 8.6% 11.0% 6.5% 8.2% 12.1% 5.8% 14.1% 13.9% 6.3%
Net margin 8.2% 2.5% 6.9% 2.8% 2.8% 6.9% −0.8% 5.8% 6.3% −0.1%
FCF margin 8.5% 6.6% 7.6% 5.9% 11.3% 1.6% 0.7% 12.3% 8.9% 4.3%
Returns
Return on capital 16.0% 8.1% 16.4% 3.6% 2.9% 5.5% 1.3% 6.8% 6.9% 1.3%
Return on capital employed 15.2% 11.1% 15.6% 3.0% 2.4% 6.0% 2.1% 8.9% 8.5% 2.3%
Return on equity 15.8% 5.0% 14.1% 3.8% 3.1% 9.0% −1.2% 8.5% 8.5% −0.2%
Return on assets 9.0% 2.9% 8.3% 1.8% 1.4% 4.2% −0.6% 4.1% 4.4% −0.1%
Growth
Revenue growth 1.2% 9.8% 5.8% 30.7% 25.1% 24.2% 10.4% 0.5% −5.8% 2.7%
Net income growth 20.0% −67.0% 193.3% −46.8% 25.4% 206.0% −113.1% — 3.5% −102.1%
EPS growth 20.6% −67.2% 192.8% −53.3% 6.7% 205.0% −113.2% — 4.0% −102.2%
FCF growth 2.2% −15.5% 22.3% 1.4% 140.2% −82.9% −51.8% 1,712.3% −32.2% −50.5%
Share count change −0.4% 0.7% 0.4% 14.0% 17.1% 0.6% 0.0% 0.3% −0.3% −2.2%
Financial health
Net debt / EBITDA −0.3x −0.4x −0.7x 10.9x 6.0x 3.4x 6.9x 2.1x 2.2x 6.1x
Debt / equity 0.2x 0.2x 0.1x 0.7x 0.7x 0.6x 0.8x 0.6x 0.6x 0.7x
Interest coverage 29.5x 46.2x 21.7x 2.7x 2.2x 6.7x 1.6x 4.2x 4.8x 1.2x
Current ratio 3.0x 2.6x 2.8x 2.0x 2.1x 2.1x 2.8x 2.5x 2.3x 2.4x
Quick ratio 2.4x 2.1x 2.1x 1.5x 1.6x 1.5x 2.0x 1.9x 1.7x 1.7x
Capital allocation
Capex / revenue 1.3% 1.3% 1.5% 1.4% 1.3% 1.2% 1.5% 2.0% 2.3% 3.0%
Stock comp / revenue 0.9% 0.5% 0.4% 0.4% 0.8% 0.6% 0.6% 0.8% 0.8% 0.7%
Payouts / FCF 36.8% 34.5% 29.3% 32.7% 17.2% 104.1% 227.1% 13.2% 50.6% 94.2%
Quality scores
Piotroski F-score 7.0 5.0 8.0 4.0 6.0 6.0 4.0 7.0 7.0 5.0
Altman Z'' 6.5 5.9 6.8 2.2 2.4 2.9 3.0 3.6 3.7 3.1
Accruals ratio −1.8% −6.3% −2.7% −2.9% −4.8% 2.5% −2.0% −6.0% −3.3% −5.1%

Source: SEC EDGAR XBRL filings (CIK 0000081362). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open